DiversityNursing Blog

Frontier Nursing University Awarded $1,998,000 Nursing Workforce Diversity Grant

Posted by Pat Magrath

Tue, Jul 25, 2017 @ 11:46 AM

blobid1_1500648981783.jpgHyden, KY -- Frontier Nursing University (FNU) has been awarded the Nursing Workforce Diversity grant from the Health Resources and Services Administration (HRSA). The grant totals $1,998,000 in funding in support of a four-year project that will be led by FNU with assistance from several key partner organizations.

The goal of the Nursing Workforce Diversity (NWD) program is to increase access to high quality, culturally-aligned advanced practice nurses and midwives that reflect the diversity of the communities in which they serve. The grant, which provides $499,500 per year, supports a proposed project in which FNU will implement a comprehensive systems approach to implementing five evidence-based strategies to support disadvantaged advanced practice nursing students from recruitment through graduation. The social determinants of education will be used as a framework to assess student needs and guide activities throughout the course of the project.

The overall aim of the program is to increase the recruitment, enrollment, retention, and graduation of students from disadvantaged backgrounds. Through education and training in Frontier Nursing University’s advanced nursing and midwifery programs, these students will be prepared to provide advanced practice nursing and midwifery health care services across the U.S.

Findings from an American Association of Colleges of Nursing policy brief (2016) found that racial and ethnic minority groups accounted for 37% of the country’s population, yet minority nurses represent only 19% of the total registered nurse workforce (National Council of State Boards of Nursing Survey, 2013).  As minority population growth rises, so does the likelihood of these populations experiencing greater health disparities such as increased rates of maternal morbidity and mortality related to childbirth, infant mortality, chronic diseases, and shorter life spans compared to the majority of Americans. There is growing evidence that greater racial diversity in the health care workforce is an important intervention to reduce racial health disparities.  

“We are extremely proud and excited to receive this grant and to be a part of such an important project,” said FNU president Dr. Susan E. Stone. “We are deeply committed to the goals of the NWD program and helping to overcome barriers that hinder the success of our underrepresented students, from recruitment through graduation.”

The project’s primary objectives are: 1) to achieve minimum of 30 percent minority student enrollment by June 2021, the end of the project period; 2) to increase the racial and ethnic minority retention rate and 3) to graduate an average of 100 new nurse-midwives and nurse practitioners representing racial and ethnic minorities underrepresented in nursing each year of the project period. 

Grant funding will support personnel, consultants, and diversity training for faculty and staff.  Retention activities, including mentor programs and writing support will also be funded.  FNU students will also benefit from substantial scholarship support and professional development opportunities.  To achieve the goals of the program, FNU will formally partner with the American Association of Colleges of Nursing (AACN), the American College of Nurse-Midwives, Midwives of Color Committee (ACNM-MOCC), the National Black Nurses Association (NBNA) and Mona Wicks, a multicultural sensitivity and diversity training expert consultant.

View the grant announcement on Frontier Nursing University's website.
 
Contact: Brittney Edwards, Director of Marketing and Communications
 
###
 
About Frontier Nursing University:
FNU is passionate about educating nurse-midwives and nurse practitioners to serve women and families in all communities, especially rural and underserved areas. FNU offers graduate Nurse-Midwifery and Nurse-Practitioner distance education programs that can be pursued full- or part-time with the student’s home community serving as the classroom.  Degrees and options offered include Doctor of Nursing Practice (DNP), Master of Science in Nursing (MSN) or Post-Graduate Certificates. To learn more about FNU and the programs and degrees offered, please visit Frontier.edu.

sign up for newsletter

Topics: Frontier Nursing University, funding, Diversity and Inclusion, Health Resources and Services Administration, Nursing Workforce Diversity Grant, FNU

Life in progress: RNs can help baby boomers find funding for promising cancer treatments

Posted by Erica Bettencourt

Fri, May 30, 2014 @ 10:52 AM

By Heather Stringer

bilde 

When Carrie Bilicki, RN, MSN, ACNS-BC, OCN, met a 60-year-old patient who had been diagnosed with aggressive endometrial cancer, she began to have a persistent — albeit unconventional — idea. 

Bilicki, a cancer nurse navigator in Wisconsin at the time, recently had attended a lecture about a progressive treatment for this type of cancer that involved using a chemotherapy drug traditionally prescribed for ovarian cancer. The patient’s cancer had spread to nearby organs, and she had a poor prognosis. Bilicki convinced the physicians to try the alternative medication. Unfortunately, the patient faced another serious hurdle: The insurance company would not cover the cost of the medication because it was not the standard treatment. At that point, the woman seemed to face the unenviable choice between cancer treatment and financial ruin.

Although patients and providers would like to hope this type of extreme dilemma is the exception, the case may be representative of the near future for two reasons. First, as a 60-year-old, the woman was a baby boomer, and researchers predict the incidence of cancer will increase dramatically as this large segment of the population ages. According to a study published in the Journal of Clinical Oncology in 2009, the U.S. can expect a 67% increase in cancer incidence among older adults between 2010 and 2030. 

Second, statistics suggest cancer treatment is becoming increasingly unaffordable, even for those with insurance who struggle to afford steep copayments. For example, The US Oncology Network — a national group of about 1,000 oncology physicians who treat more than 750,000 cancer patients per year — reported about half of the patients covered by a Medicare Part D plan have required copay assistance for oral chemotherapy for the past several years.

“My message to my peers is to know the financial resources available because there are hundreds of them,” Bilicki, who now is a clinical nurse specialist in breast services at Froedtert Center for Diagnostic Imaging in Milwaukee, Wis., said. “There are foundations, specialty organizations and websites that tell us where to get help. If a patient does not have an advocate to link them to that resource, they will never know it is available.” 

What's new?

For many patients, the desire to find a way to afford medication is driven not only by the fact that they have cancer, but also because the treatment options available today have increased the odds of survival. 

“By far one of the biggest advancements is more personalized medicine that targets cancer cells rather than traditional chemotherapy that did not differentiate between good and bad cells,” Kim George, RN, MSN, ACNS-BC, OCN, a cancer program consultant from Wichita Falls, Texas, said. “For example, now we can test biopsy tissue for specific tumor antigens and biomarkers and then prescribe treatments that target those antigens.” 

The advancements in cancer treatment also are reflected in improved survival rates. According to the Surveillance Epidemiology and End Results Cancer Statistics Review 1975-2009, for example, the 5-year survival rate for breast cancer among women in the U.S. between 1975 and 1977 was 75%. Between 2002 and 2008 that number jumped to 90%. During the same time periods, the 5-year survival rate for both men and women with colon cancer has increased from 50% to 65%. 

“Another major advancement has been the increase in availability of oral chemotherapy and biotherapy,” George said. “It has shifted the care setting. Years ago, the majority of cancer patients received IV infusions, and now more patients can take their medication orally at home. It is wonderful for convenience, and it is also less painful.” 

However, George said, reimbursement is not always a given with oral chemotherapy. “A lot of oncology medications are given off-label, which means that the FDA has not approved a drug for a specific diagnosis, so it may not be covered by some insurance policies,” she said. 

A little help can mean a lot

Point the way for patients who need assistance financing cancer treatments, by seeking resources such as the following:

• PatientAdvocate.org — Provides sources for copay assistance and answers questions about disability and insurance processes

• PatientResource.com — Features information on different types of cancer, newsletters and financial and advocacy resources

• CureToday.com — Provides an extensive list of national resources for advocacy, financial and pharmaceutical assistance

• RxOutreach.org — A nonprofit organization that helps low-income families who cannot afford the medication they need 

• CDFund.org — Chronic Disease Fund — A nonprofit organization that helps patients obtain lifesaving medications

For a list of drug assistance programs from pharmaceutical companies, visit Cancersupportivecare.com/drug_assistance.html.



Point the way

The art of navigating the path to financial assistance for cancer medication is not simple, and organizations such as The US Oncology Network, based in The Woodlands, Texas, have hired professionals to help patients connect with funding resources and launched the OncologyRx Care Advantage pharmacy in 2006. Nurses in the network can refer patients to Care Advantage staff who help them apply for financial assistance. 

“The types of drugs used to treat cancer today are definitely more expensive than when I started working in oncology almost 30 years ago,” said Lori Lindsey, RN, MSN, NP, OCN, a clinical services program manager with The US Oncology Network. “Multidrug regimens, including oral targeted therapies, can sometimes cost $30,000 for a round of treatment, although the use of these drugs has markedly improved outcomes and increased survival for some diseases.” 

For patients who are uninsured, the best option is to apply directly to the drug manufacturer for patient assistance, said Meg Asher, a patient access coordinator/patient advocate lead at the Care Advantage pharmacy. “When we learn that a patient is without insurance, we notify the doctor’s office and send a manufacturer’s application to them for the patient’s use,” Asher said. “Under these circumstances, we will not be the dispensing pharmacy; the manufacturer has their own specified pharmacy that will service the patient.”

Even those who are insured under Medicare Part D often require assistance because the copayments can be thousands of dollars, Asher said. For these patients, the Care Advantage advocate team helps patients connect with various foundations that provide copay assistance in the form of grants. Some of the foundations assist patients who suffer from a specific disease, while others help those who are taking a specific drug for a disease. 

While some facilities have staff trained to help patients find financial assistance, this is not always the case. For these patients, one resource is the Patient Advocate Foundation, a nonprofit organization with case managers who help patients with life-threatening illnesses to maintain financial stability. 

“When I was a hospital nurse, I honestly didn’t know about a lot of the resources available to help patients after they left my care,” Pat Jolley, RN, the clinical director of research and reporting at PAF, said. “Many people have never had to ask for financial help in the past, and they are unaware that there are options. If they are newly diagnosed, we try to educate them about the likely expenses down the road to help identify potential problems. In my experience, when patients contact us saying they cannot afford one thing, it is usually just the tip of the iceberg.” 

For example, PAF assisted a 62-year-old woman with breast cancer who was insured, but she was having difficulty scheduling her needed mastectomy because of outstanding medical bills. She was living on Social Security disability payments, and her insurance did not cover surgeries, scans or tests. The woman received a bill for $50,000 that included the cost of previous care and several office visits. By negotiating with the hospital and the providers, the PAF case manager was able to reduce the bill to a total of $950 and also facilitate the scheduling of her mastectomy. 

Suffering in silence

For Bilicki, one of her personal goals is to encourage patients to consider the financial aspect of their cancer care before they decide to pursue a particular form of treatment. 
“Nobody wants to talk about their financial state, and I think far too often patients suffer in silence rather than saying that they are having trouble with copayments, so what I do is proactively tell them about some of the resources,” Bilicki said. “Just because they have insurance does not mean they will have resources to afford the costs, so I empower all patients right off the bat to proactively seek out assistance if they need it.”

After patients have been diagnosed with cancer, Bilicki encourages them to learn about the resources at the American Cancer Society, which has patient navigators trained to help people connect with financial resources. She also tells them about a group called Patient Resource LLC, which has a website and a patient magazine that includes national, state and local resources available for financial assistance. 
In the case of the woman with endometrial cancer who could not afford a medication that was not covered by her insurance, Bilicki helped her apply for the drug manufacturer’s patient assistance program. Based on her income and medical necessity, she qualified for full assistance. She was on the medication for 15 months, and, despite her initial grim prognosis, the cancer has been in remission for the past five years. 

“I can always remember the tears and fear in their eyes when I first meet patients, and each time it feels like I’ve won the lottery when I help them secure the treatment they need, and they start smiling again,” Bilicki said. “Part of my big mission for my colleagues is to advocate for these patients so they do not miss out on options that can change their lives.” 

A little help can mean a lot

Point the way for patients who need assistance financing cancer treatments, by seeking resources such as the following:

• PatientAdvocate.org — Provides sources for copay assistance and answers questions about disability and insurance processes
• PatientResource.com — Features information on different types of cancer, newsletters and financial and advocacy resources
• CureToday.com — Provides an extensive list of national resources for advocacy, financial and pharmaceutical assistance
• RxOutreach.org — A nonprofit organization that helps low-income families who cannot afford the medication they need 
• CDFund.org — Chronic Disease Fund — A nonprofit organization that helps patients obtain lifesaving medications
For a list of drug assistance programs from pharmaceutical companies, visit Cancersupportivecare.com/drug_assistance.html.

Source: Nurse.com

Topics: babyboomers, RN, nurses, cancer, funding

Overheard on CNN: Less pink, more cures for breast cancer

Posted by Alycia Sullivan

Fri, Oct 26, 2012 @ 03:01 PM

From CNN

breastcancera

Many CNN commenters expressed skepticism about the so-called “pinkwashing” of October, echoing the sentiments of some women quoted in my recent article who don't feel connected to all of the awareness efforts.

KtinME writes that the color pink is particularly vexing to her because it has come to represent the commercialization of breast cancer awareness:

I criticized my hospital for using pink envelopes when mailing out mammogram results and was told in no uncertain terms that pink was the color of caring and compassion and that I obviously had issues with fear of breast cancer. I don't have a fear of breast cancer, but I will agree I have issues with the commercialism and complete co-opting of the color pink.

Pink envelopes with mammogram results are creepy. Pink shoes on football players are stupid. Pink merchandise is just plain silly. I used to like pink.

[…] a COLOR is meaningless when it comes to what cancer patients need and a COLOR is an easy way out for people to think they're being supportive of cancer awareness, cancer patients, and cancer survivors. How about instead we give them rides for their treatment, clean homes to come to, meals to eat, affordable access to medical care at home? How about we make sure their employers keep their jobs open for them? How about we make sure they have insurance now and forever? THOSE things would mean a lot more than sporting a pink bracelet or buying something pink. Enough with the pink!!!

Several readers such as Anthony Quatroni believe that “it’s all about money” – in other words, curing diseases isn’t as profitable as long-term treatments, so a cure will never be found.

But prattguy, self-identified as someone who works in medical research, pointed out that polio is a disease that was cured, yet foundations are still working to eradicate it worldwide.

Klur added that cancer is not one disease, it’s many diverse diseases even within a single organ. But there’s good news:

Many women who get breast cancer now survive to live a long and fruitful life thanks to advancements in cancer research. So, no, the reason for research investment is not greed!!! Furthermore, people who work in academia doing research are not getting rich- believe me- they are overworked and highly underpaid for the research that they dedicate their lives to.

Bschneid agreed, reminding fellow commenters that a lot of people dedicated to cancer research aren’t making such big profits:

Most cancer researchers do not make a lot of money, but are either cancer survivors themselves or have a loved one who has cancer or died of cancer. They have plenty of motivation. My husband, a cancer researcher, goes to work seven days a week while dealing with chemotherapy himself. To suggest that greed is the reason there is no "cure" for cancer is ignorant.

Some pointed out that other awareness months don’t get nearly as much attention. TexasRunner wrote:

This isn't a man vs. woman issue. September is National Prostate Awareness month but does it garner as much attention as the PINK does for breast cancer in October? No, it doesn't. Men deal with our own forms of cancer like prostate cancer and testicular cancer yet the drives to find a cure for those forms of cancer pale in comparison, usually because it hits a lower number for testicular cancer and for prostate cancer it happens at an older age. Do you not think men who have testicular cancer aren't aware of the jokes surrounding it?

So regardless of whether or not you like the slogans at least people pay attention and are aware and donate to find a cure.

Topics: breast cancer, cure, funding

Click me

Article or Blog Submissions

If you are interested in submitting content for our Blog, please ensure it fits the criteria below:
  • Relevant information for Nurses
  • Does NOT promote a product
  • Informative about Diversity, Inclusion & Cultural Competence

Agreement to publish on our DiversityNursing.com Blog is at our sole discretion.

Thank you

Subscribe to Email our eNewsletter

Posts by Topic

see all